Be sure to check our sister interview main ratings news website

UBM

Hardman & Co

Ulisse BioMed: Molecular diagnostic game changer

7th September 2021

Ulisse BioMed (UBM) has developed three technology platforms that offer great potential, having wide applications in molecular diagnostics and immunoassay. Its most developed product – a polymerase chain reaction (PCR)

Interviews

Valeura Energy Strategic Acquisitions and Successful Exploration Boosting Shares and Reserves
Valeura Energy Strategic Acquisitions and Successful Exploration Boosting Shares...
Valeura Energy Inc. (TSX:VLE) is the...
Team Plc Positive Q1 and Strategic Outlook for 2024 with Craig Farley (VIDEO)
Team Plc Positive Q1 and Strategic Outlook for 2024...
TEAM Plc (LON:TEAM) Head of Multi-Asset...
Gattaca Plc on Path for Sustainable Growth after Resilient Performance and Strategic Adjustments (VIDEO)
Gattaca Plc on Path for Sustainable Growth after Resilient...
Gattaca plc (LON:GATC) CEO Matthew Wragg,...
Valeura Energy’s Strategic Surge in Thailand’s Oil Industry (VIDEO)
Valeura Energy’s Strategic Surge in Thailand’s Oil Industry (VIDEO)
Valeura Energy (TSX:VLE) have today published...
Diversified Energy Company Receives Positive Model Update by Peel Hunt (VIDEO)
Diversified Energy Company Receives Positive Model Update by Peel...
Diversified Energy Company (LON:DEC) is the...

Funds

Gold price surges to record highs amid US Inflation
Gold price surges to record highs amid US Inflation
Private debt investing: Exploring Collateralized Loan Obligations
Private debt investing: Exploring Collateralized Loan Obligations
Global equity markets decline as rate-cut expectations shift
Global equity markets decline as rate-cut expectations shift
Volta Finance Limited reports 6.3% returns in Q1 2024 (LON:VLA)
Volta Finance Limited reports 6.3% returns in Q1 2024 (LON:VLA)
BlackRock Sustainable American Income Trust NAV increased by 4.9%, share price by 7.9%
BlackRock Sustainable American Income Trust NAV increased by 4.9%, share price by 7.9%
TEAM plc: Hannam & Partners’ Ben Williams discusses Wealth Management Potential and Growth Opportunities
TEAM plc: Hannam & Partners’ Ben Williams discusses Wealth Management Potential and Growth Opportunities

Presentations

Time Finance Plc Q3 Results and Profit Upgrades with Ed Rimmer CEO (VIDEO)
Time Finance Plc Q3 Results and Profit Upgrades with...
Time Finance Plc (LON:TIME) CEO Ed...
Poolbeg Pharma A Strategic Vision, Pioneering the Future of Innovative Medicine
Poolbeg Pharma A Strategic Vision, Pioneering the Future of...
A Poolbeg Pharma Plc (LON:POLB) Investor Presentation...
Cerillion plc Overview and Annual Results by CEO & CFO
Cerillion plc Overview and Annual Results by CEO &...
Cerillion plc (LON:CER) Overview and Annual...
Likewise Group Tony Brewer: Capturing beyond 10% of £2 billion flooring market (Video)
Likewise Group Tony Brewer: Capturing beyond 10% of £2...
Likewise Group plc (LON:LIKE) CEO Tony...
East Imperial Plc 2023 interims and strategic plans by Tony Burt, CEO
East Imperial Plc 2023 interims and strategic plans by...
East Imperial Plc (LON:EISB) CEO and...

Broker Talk

Chesnara Plc 2023 results show Positive Returns, Dividend Increase, and Undervalued Stock
Chesnara Plc 2023 results show Positive Returns, Dividend Increase, and Undervalued Stock
Tissue Regenix Group: Profitable and Cash-Generating Growth Strategy 2024
Tissue Regenix Group: Profitable and Cash-Generating Growth Strategy 2024
NB Private Equity Partners Ltd: Value creation evolution and investment summary
NB Private Equity Partners Ltd: Value creation evolution and investment summary
RECI – Hardman research underlines its strong liquidity and portfolio resilience, Feb 2024
RECI – Hardman research underlines its strong liquidity and portfolio resilience, Feb 2024
City of London Investment Group reports strong growth and cost reductions in Q2 2024
City of London Investment Group reports strong growth and cost reductions in Q2 2024
Accrol Group: strong margins and volume growth continues into H2, says Shore Capital
Accrol Group: strong margins and volume growth continues into H2, says Shore Capital

© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.